CS

Chemcon Speciality Chemicals Ltd

Q4 FY25Chemicals & Petrochemicals

Chemcon Speciality Chemicals Ltd Q4 FY25 Results & Presentation Highlights: Revenue, Margins & Order Book

Q4 FY25 investor presentation: what the company reported on revenue, margins and projects.

Price₹228
Market cap₹793 Cr
P/E28.1
Updated24 Sept 2026
Read4 min read

Based on Chemcon Speciality Chemicals Ltd's Q4 FY25 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.

The short version

Q4 FY25 Revenue from Operations: Rs. Q4 FY25 EBITDA: Rs.

From Chemcon Speciality Chemicals Ltd's Q4 FY25 earnings-call transcript · updated 24 Sept 2026.

Revenue & Sales Performance

  • Q4 FY25 Revenue from Operations: Rs. 54.9 Crs, down 8% YoY from Rs. 59.6 Crs in Q4 FY24 (Page 8, 6)
  • Q4 FY25 Sales Volume:
  • Inorganic Chemicals: 1,186 MT (down from 1,314 MT in Q4 FY24)
  • Organic Chemicals: 1,024 MT (down from 2,124 MT in Q4 FY24) (Page 6)
  • YoY PAT for Q4: Rs. 3.9 Crs, up 36% from Rs. 2.9 Crs (Page 8)
  • Outlook:
  • Early signs of recovery in demand for some organic chemicals
  • New products for import substitution undergoing client approvals and trial dispatches, expected to have commercial potential soon

2 more points management made on revenue & sales performance

Profitability & Margins

See what Chemcon Speciality Chemicals Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Planned capacity expansion includes two new manufacturing units: P-10 and P-11 at Manjusar, Gujarat.
  • Both units will manufacture organic chemicals.
  • Commissioning of P-10 and P-11 units is targeted for the first half of FY26 (H1 FY26).
  • No specific capex amounts are stated in the presentation.
  • These expansions aim to support pharmaceutical applications and diversify product portfolio, aligning with import substitution and growth strategy.
  • Two proposed expansion plants are under process, located at Manjusar near Vadodara.
  • Installed capacity for existing organic chemicals is 11,400 MTPA with inorganic chemicals capacity at 15,000 MTPA; new units expected to add to organic chemicals capacity.

2 more points management made on capital expenditure plans

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

5x potential
Rev 1Mar 2
2Yasho Industries
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Chemcon Speciality Chemicals Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The investor presentation does not explicitly report any figures or details related to order book, order inflow, or pending orders. The following points summarize relevant related information: - No specific mention or data is provided on the size or value of the current order book. - There is no disclosure of order inflow rates or trends during the reported periods. - No information on pending or backlogged orders is included.

2 more points management made on order book & pipeline

Chemcon Speciality Chemicals Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹75 Cr, net profit ₹6 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Atul Ltd (Q4 FY25)

    Consolidated revenue from operations for 2024-25: ₹5,583 cr, 18% increase YoY from ₹4,726 cr in 2023-24 (Page 36). Key investor presentation takeaways from Atul

  • Vidhi Specialty Food Ingredients Ltd (Q4 FY25)

    109.5 Crs, up 40.2% YoY (from Rs. Key investor presentation takeaways from Vidhi Specialty Food Ingredients Ltd's Q4 FY25 investor presentation — and how it ran

  • Valiant Organics Ltd (Q4 FY25)

    Q4-FY25 revenue from operations (consolidated) was INR 2,038 million, a 15.3% year-on-year (YoY) increase from INR 1,768 million in Q4-FY24 (Page 12 and 10)…

  • Clean Science (Q4 FY25)

    2,500 crores to Rs. Key concall takeaways from Clean Science's Q4 FY25 earnings call — and how it ranks against sector peers.

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Chemcon Speciality Chemicals Ltd Q4 FY25 results?

Q4 FY25 Revenue from Operations: Rs. Q4 FY25 EBITDA: Rs.

What is Chemcon Speciality Chemicals Ltd share price analysis?

Chemcon Speciality Chemicals Ltd currently shows a neutral. The stock trades at a P/E of 28.1 with a market cap of ₹793 Cr. Investors should review the full earnings analysis for detailed insights.

Is Chemcon Speciality Chemicals Ltd planning capital expenditure?

Planned capacity expansion includes two new manufacturing units: P-10 and P-11 at Manjusar, Gujarat.

Keep Chemcon Speciality Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.